Schabel Fm
About
In The Last Decade
Schabel Fm
59 papers receiving 1.7k citations
Hit Papers
Peers
Comparison fields: 5 of 106
- Oncology 941
- Molecular Biology 766
- Pulmonary and Respiratory Medicine 335
- Cancer Research 251
- Hematology 220
Countries citing papers authored by Schabel Fm
This map shows the geographic impact of Schabel Fm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Schabel Fm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Schabel Fm more than expected).
Fields of papers citing papers by Schabel Fm
This network shows the impact of papers produced by Schabel Fm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Schabel Fm. The network helps show where Schabel Fm may publish in the future.
Co-authorship network of co-authors of Schabel Fm
This figure shows the co-authorship network connecting the top 25 collaborators of Schabel Fm. A scholar is included among the top collaborators of Schabel Fm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Schabel Fm. Schabel Fm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Tumor stem cell heterogeneity: implications with respect to classification of cancers by chemotherapeutic effect. | 49 |
| 2 | cis-Dichlorodiammineplatinum(II): combination chemotherapy and cross-resistance studies with tumors of mice. breakdown → | 357 |
| 3 | Fundamentals in cancer chemotherapy: introduction. | 1 |
| 4 | Therapeutic potentiation of nitrosoureas using chlorpromazine and caffeine in the treatment of murine tumors. | 7 |
| 5 | Biology and therapeutic response of a mouse mammary adenocarcinoma (16/C) and its potential as a model for surgical adjuvant chemotherapy. | 82 |
| 6 | Experimental therapeutics and kinetics: selection and overgrowth of specifically and permanently drug-resistant tumor cells. | 54 |
| 7 | Studies with 2,5-piperazinedione, 3,6-bis(5-chloro-2-piperidyl)-,dihydrochloride. III. Biochemical and therapeutic effects in L1210 leukemias sensitive and resistant to alkylating agents: comparison with melphalan, cyclophosphamide, and BCNU. | 3 |
| 8 | Basic and therapeutic trial results obtained in the spontaneous AK leukemia (lymphoma) model-end of 1971. | 23 |
| 9 | The "sensitivity" of resting and dividing cells. | 3 |
| 10 | Implications of biochemical, cytokinetic, pharmacologic, and toxicologic relationships in the design of optimal therapeutic schedules. | 215 |
| 11 | Response to therapy of spontaneous, first passage, and long passage lines of AK leukemia. | 23 |
| 12 | Chemotherapy of leukemia L1210 by 6-mercaptopurine (NSC-755) in combination with 6-methylthiopurine ribonucleoside (NSC-40774). | 4 |
| 13 | Experimental evaluation of potential anticancer agents. XXI. Scheduling of arabinosylcytosine to take advantage of its S-phase specificity against leukemia cells. | 178 |
| 14 | VIRUS CHEMOTHERAPY - WHY AND HOW. | 2 |
| 15 | Experimental evaluation of potenital anticancer agents. XVII. Kinetics of growth and regression after treatment of certain solid tumors. | 35 |
| 16 | EXPERIMENTAL EVALUATION OF POTENTIAL ANTICANCER AGENTS. XIV. FURTHER STUDY OF CERTAIN BASIC CONCEPTS UNDERLYING CHEMOTHERAPY OF LEUKEMIA. | 53 |
| 17 | Development of Friend leukemia virus in spleen and plasma of Swiss mice. | 2 |
| 18 | Experimental evaluation of potential anticancer agents. X. A specificity test for distinguishing false positives. | 2 |
| 19 | Experimental evaluation of potential anticancer agents. II. Studies on the growth characteristics, metastases, and drug response of hamster neoplasms of diverse "sites of origin". | 7 |
| 20 | Studies on the mechanism of action and anticancer activity of N-methylformamide. | 17 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.